According to Future Market Insights research, during the projected period, the global IV disposables market is expected to grow at a CAGR of 11.8%. The market value is projected to increase from USD 17.0 Billion in 2023 to USD 51.6 Billion by 2033. The IV disposables market was valued at USD 15.5 Billion at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 9.6% in 2023.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | USD 15.5 Billion |
| Market Value 2023 | USD 17.0 Billion |
| Market Value 2033 | USD 51.6 Billion |
| CAGR 2023 to 2033 | 11.8% |
| Share of Top 5 Countries | 60.4% |
| Key Players | The key players in the IV disposables market are B. Braun Melsungen AG; Baxter; 3M; Terumo Corporation; Nipro Corporation; Teleflex Incorporated; Becton; Dickinson and Company; Smiths Medical/ICU Medical; Moog Inc; AngioDynamics.; Fresenius SE & Co. KgaA; arcomed ag |
IV disposables, also known as intravenous disposables, are medical devices and accessories used in intravenous therapy to administer fluids, medications, and other substances directly into a patient's bloodstream. These disposable products are designed for single use and are discarded after each patient to minimize the risk of contamination and infection.
An increasing number of chronic diseases demanding disposable IV therapy products is expected to be a major factor driving the growth of the global disposable IV therapy products market over the forecast period.
Overall, the increasing number of chronic diseases due to several factors is likely to boost the market in the coming years.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales of the IV disposables market grew at a CAGR of 8.6% between 2018 to 2022. IV disposables market contributes 11.5% revenue share to the global medical supplies market which is valued around USD 134.2 Billion 2022.
The demand for IV disposables has been steadily increasing due to factors such as the rising prevalence of chronic diseases, an aging population, and the expansion of healthcare infrastructure.
Diabetes is one of the leading cause of kidney failure, lower-limb amputations, and new cases of impaired vision among adults. Moreover, health risks by the dearth of exercise, high alcohol and tobacco consumption, and poor nutrition cause much illness and early death due to chronic diseases.
The market is expected to continue growing during the forecast period. Factors such as the increasing prevalence of chronic diseases, ongoing advancements in medical technology, and the expansion of healthcare services in developing regions are likely to drive the market's growth.
The COVID-19 pandemic has highlighted the importance of IV therapy in critical care settings, further emphasizing the need for IV disposables. The market is also expected to benefit from the continued focus on infection control and the adoption of advanced healthcare technologies.
Considering this, FMI expects the global market to grow at a CAGR of 11.8% through the forecasted years.
The demand for IV therapy has increased as the prevalence of chronic diseases like diabetes, cancer, and coronary artery disease has increased. IV disposables are essential for giving patients their fluids, drugs, and nutrition, which opens up new business prospects for providers and manufacturers.
Technological advancements in the intravenous equipment market include smart pumps, wireless and remote monitoring, needle-free ports, closed system transfer devices, portable intravenous devices, and nanotechnology. These advances have the potential to improve the safety, effectiveness, and efficiency of intravenous therapy and create new opportunities for manufacturers in this market.
There is a growing demand for smart pumps, a type of infusion pumps, that use advanced software algorithms to improve the accuracy and safety of intravenous drug administration. They can detect potential errors, such as incorrect dosages or administration rates, and alert healthcare professionals. These factors can open up several opportunities in the intravenous equipment market.
Principal Consultant
The high cost of intravenous equipment can limit their acceptability in some healthcare settings, especially those with limited budgets. Healthcare providers may opt for lower-cost alternatives, such as oral medications or subcutaneous injections, which may limit the growth of the intravenous equipment market. Healthcare providers may face lower profit margins due to the high cost of intravenous equipment, which may limit their willingness to invest in new equipment or expand their services.
Product recalls can affect the intravenous equipment market in the United States by damaging brand reputation, reducing revenue, increasing regulatory scrutiny, raising patient safety concerns, and increasing litigation costs. Product recalls can raise patient safety concerns and limit the adoption of intravenous equipment by healthcare providers. This may impact the overall growth of the intravenous equipment market.
Some of the factors that can increase demand for alternative therapies include reducing demand, limiting cost-effectiveness, patient preference, limiting investment in innovation and research, and regulatory challenges.
Alternative therapies may be more cost-effective for healthcare providers and insurance companies because they require less equipment and human resources. This may limit the adoption of intravenous equipment and affect the overall growth of the market.
These factors are expected to hamper the revenue growth of the market over the forecast period.
The USA market is expected to register a CAGR of 10.3% during the forecast period.
The demand for IV disposables in the USA is driven by factors such as the aging population, the need for improved patient care and safety, the expansion of healthcare infrastructure, and the growing focus on infection control.
The USA market is highly competitive, with several prominent companies operating in the industry. These companies compete based on factors such as product innovation, pricing strategies, distribution networks, and relationships with healthcare providers, which will drive the expansion of the market.
Germany dominated the European market for IV disposables and accounted for around 29.8% of the market share in 2022.
Germany has a robust healthcare infrastructure with a well-established network of hospitals, clinics, and healthcare facilities. The country is known for its high-quality healthcare services and advanced medical technology. This infrastructure creates a favorable environment for the adoption and utilization of IV disposables, driving market growth.
Germany is a lucrative segment of the market in Europe. The strong healthcare infrastructure, technological advancements, aging population, stringent regulations, reimbursement system, medical tourism, and emphasis on research and development create a favorable market landscape for IV disposable manufacturers and suppliers.
China is projected to be the most attractive market in IV disposables and is expected to grow over a significant CAGR of 11.8%.
The market in China is expected to grow significantly in the coming years due to several factors. China has been increasing its healthcare expenditure in recent years, with a focus on improving healthcare infrastructure and services. This increased investment in the healthcare sector is expected to drive the demand for IV disposables as the country seeks to enhance patient care and treatment outcomes.
Another factor contributing to the growth of the market in China is the prevalence of chronic diseases such as cardiovascular diseases, diabetes, and cancer is on the rise in China, primarily due to factors like an ageing population, sedentary lifestyles, and changing dietary patterns. IV therapy is often necessary for the management and treatment of these chronic conditions, leading to an increased demand for IV disposables.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The infusion pumps segment held the major chunk of about 48.1% of the global market by the end of 2022.
Infusion pumps offer precise and controlled administration of fluids, medications, and nutrition to patients. They are designed to deliver these substances at specific rates and volumes, ensuring accuracy and consistency in dosage. This level of precision is critical in many medical scenarios, such as critical care, chemotherapy, and pain management.
IV disposables, such as specialized connectors and pressure sensors, are designed to work in conjunction with infusion pumps to ensure the safe and accurate delivery of fluids and medications.
Overall, infusion pumps are a widely adopted treatment option for IV Disposables due to their precise and controlled administration of fluids and medications, enhanced safety features, and compatibility with various IV disposables.
The hospitals accounted for a revenue share of 54.6% in the global market at the end of 2022.
Hospitals typically have a significantly higher volume of patients compared to other healthcare settings such as clinics or ambulatory surgical centers. This higher patient load translates into greater demand for IV therapy, which drives the need for IV disposables. Hospitals often have multiple departments and units that administer IV treatments, including emergency departments, intensive care units, operating rooms, and general wards, further contributing to the demand for IV disposables.
Hospitals primarily provide inpatient services, where patients stay for an extended period during treatment or recovery. In such cases, patients often require continuous or intermittent IV therapy throughout their hospital stay. This continuous demand for IV disposables further solidifies the dominance of hospitals in the IV disposable market.
Key players in the market are focused on increasing their product portfolio for strengthening their position in the market and to expand their footprint in emerging markets. The key strategy adopted by manufacturers to gain a competitive edge in the market is pricing strategies, market strategies, technological advancements, and acquisition with other companies to expand their business.
For instance
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the IV disposables market space, which are available in the full report
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania and Middle East & Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, UK, France, Italy, Spain, Russia, BENELUX, Nordics, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Vietnam, Philippines, Australia, New Zealand, Türkiye, South Africa, North Africa and GCC Countries |
| Key Segments Covered | Product, End User, and Region |
| Key Companies Profiled | B. Braun Melsungen AG; Baxter; 3M; Terumo Corporation; Nipro Corporation; Teleflex Incorporated; Becton, Dickinson and Company; Smiths Medical/ICU Medical; Moog Inc; AngioDynamics.; Fresenius SE & Co. KgaA; arcomed ag |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is valued at USD 17.0 billion in 2023.
B. Braun Melsungen AG, Baxter International Inc., and 3M are key market players.
The healthcare industry is the key consumer of the IV disposables market.
The market is estimated to reach USD 51.6 billion by 2033.
The IV Disposables Market CAGR for 2033 is 11.8%.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Value-Added Insights 5. Market Background 6. Global Market Demand Volume (Units) Analysis 2018 to 2022 and Forecast, 2023 to 2033 7. Global Market Demand Pricing Analysis 2018 to 2022 and Forecast, 2023 to 2033 8. Global Market Demand (in Value or Size in USD Million) Analysis 2018 to 2022 and Forecast, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 9.1. Intravenous Administration Set 9.2. IV Fluid Solution Bags 9.3. IV Cannula 9.4. Infusion Sets 9.5. Infusion Pumps 9.6. Catheter Needles 9.7. Securement Devices 9.8. Others (Stopcocks, connectors, Extension Tubes) 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 10.1. Hospitals 10.2. Ambulatory Surgical Centers 10.3. Specialty Clinics 10.4. Home Care Settings 11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 11.1. North America 11.2. Latin America 11.3. Europe 11.4. South Asia 11.5. East Asia 11.6. Oceania 11.7. Middle East & Africa 12. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 17. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033 18. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 19. Market Structure Analysis 20. Competition Analysis 20.1. B. Braun Melsungen AG 20.2. Baxter 20.3. 3M 20.4. Terumo Corporation 20.5. Nipro Corporation 20.6. Teleflex Incorporated 20.7. Becton, Dickinson, and Company 20.8. Smiths Medical/ICU Medical 20.9. Moog Inc 20.10. AngioDynamics 20.11. Fresenius SE & Co. KgaA 20.12. arcomed ag 21. Assumptions and Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports
IV Disposables Market
